Combination Study of SV-BR-1-GM With Retifanlimab
Status: ENROLLING_BY_INVITATION
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Neoplasm|Metastatic Breast Cancer|Breast Cancer Metastatic
Interventions: BIOLOGICAL: SV-BR-1-GM|DRUG: Low dose cyclophosphamide|DRUG: Interferon Inoculation|DRUG: retifanlimab
Sponsor: BriaCell Therapeutics Corporation
Collaborators: LumaBridge